Search for: "Human Genome Sciences Inc. "
Results 81 - 100
of 125
Sorted by Relevance
|
Sort by Date
26 Apr 2015, 6:14 pm
As an example if one considers how inventive step was assessed in Teva UK Limited & Teva Pharmaceuticals Limited v Leo Pharma A/S & Leo Laboratories Limited [2014] EWHC 3096 (Pat) (see Katpost here) one sees that for a pharmaceutical formulation the following criteria may be relevant:* obvious to try * reasonable expectation of success * prejudice * inventive selection * the Technograph test (Technograph v Mills & Rockley [1972] RPC 346) * synergyMr Justice Birss… [read post]
23 Dec 2008, 7:00 pm
Several highlights: Four companies adopted the proposal seeking the repeal of the classified structure of the board of directors and calling for the annual election of all directors: Cumulus Media, Inc.; Human Genome Sciences; O'Charley's Inc.; and Stone Energy Corporation. [read post]
19 Nov 2015, 6:38 pm
FDA said it had based the decision “on sound science and a comprehensive review” and had concluded that consumption of the GE salmon poses no threat to human safety or the environment. [read post]
17 Sep 2020, 6:14 am
One respondent replied that it was ‘hard to tell’ given that so many decisions take place off camera in secret meetings,’ while another acknowledged that ICOC members are human, and, of course, their decisions are influenced by personal beliefs and interests. [read post]
31 Oct 2011, 3:42 am
A. v Kookmin Bank, heard 27 July 2011, and Human Genome Sciences Inc v Eli Lilly and Company, heard 18 – 21 July 2011. [read post]
9 Jun 2021, 8:28 am
In its most recent manifestations one sees the imposition of public pressure on the National Basketball Association and on Apple Inc. respecting their entanglement in Xinjiang that increasingly serves as the defining point for the difference between US and Chinese normative approaches to public governance; here and here). [read post]
26 May 2015, 7:42 am
Essentially, the allegations seek to impose a non-FDA-approved contraindication, using state law, based upon human genetic variability. [read post]
17 Apr 2013, 11:50 am
A writ of certiorari was granted by the Supreme Court, which vacated the Court of Appeal's decision, remanding the case for re-evaluation, in light of Mayo Collaborative Services v Prometheus Laboratories Inc. [read post]
1 Mar 2011, 8:38 pm
Roche Molecular Systems, Inc. [read post]
21 Jul 2014, 10:32 am
”Even here, however, we see signs that UK courts are trying to be more consistent with the EPO, and in the HGS v Lilly litigation, reading the decision of the Supreme Court in Human Genome Sciences Inc. v Eli Lilly and Company [2011] UKSC 51 (see IPKat here) it is possible discern in the judgment a desire to not only apply the jurisprudence of the EPO Boards of Appeal, but also to reach the same conclusion (of sufficiency of the claims) on the specific… [read post]
19 Aug 2012, 10:03 pm
Supply, Inc v. [read post]
2 Nov 2011, 4:53 am
The Kat had this brilliant idea for what you get when you cross 'Neutrokine-a' with 'genome' Hot off the press and not yet digested, this morning's ruling of the United Kingdom's Supreme Court in Human Genome Sciences Inc. v Eli Lilly and Company [2011] UKSC 51, will be the subject of considerable analysis in the coming days and weeks. [read post]
27 Dec 2021, 10:05 pm
Appx. 774 (9th Cir. 2012) (“USDA responded to the Hornes’ rulemaking petition—as it must under the Administrative Procedure Act”); WWHT, Inc. v. [read post]
20 Aug 2011, 10:41 pm
After Benhamou notified him that there were certain problems with the medication, in 2008 Skowron had the hedge fund get rid of millions of dollars of shares in the company (the funds’ holdings of Human Genome Sciences Inc. [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
31 Jan 2018, 10:05 pm
Article 3(a): a spectrum of specificity The Court of Appeal reviewed the case law of the CJEU and pending references, focussing on Case C-322/10 Medeva BV v Comptroller-General of Patents, Designs and Trade Marks and Case C-493/12 Eli Lilly & Co Ltd v Human Genome Sciences Inc. [read post]
11 Sep 2012, 12:30 am
Meanwhile, over on PatLit, IPKat team blogger Jeremy reflects on the purchase in mid-litigation of patent-owning Human Genome Sciences Inc by Glaxo SmithKline, and on IP Tango Patricia Covarrubia previews a forthcoming seminar in Brazil on IP and sport, as the country prepares itself for the next soccer world cup (2014) and summer Olympics (2016). [read post]
20 Dec 2010, 10:32 am
In addition to today’s charges, the Department of Justice and SEC last month announced parallel actions against a French doctor and expert consultant who, while a member of the steering committee overseeing one of Human Genome Science Inc. [read post]
13 Oct 2015, 10:01 pm
“If the science shows there’s not a problem, the agency will be flexible,” he said. [read post]
31 Jan 2023, 7:39 am
See, e.g., Andrew See, “Use of Human Epidemiology Studies in Proving Causation,” 67 Def. [read post]
